Following the oligonucleotide trail from synthesis to therapeutic delivery

What powers the journey from oligonucleotide synthesis to therapeutic delivery?


From research tool to therapeutic powerhouse, oligonucleotides are transforming modern life science. Their expanding role in areas such as polymerase chain reaction (PCR), functional genomics, small interfering RNA (siRNA), and precision medicine is driving demand for increasingly sophisticated approaches to synthesis, characterization, analysis, and delivery. Supporting these workflows requires a diverse ecosystem of technologies designed to ensure quality, reproducibility, and performance from discovery through to therapeutic development.

Achieving this requires careful consideration at every step of the workflow. Decisions made during oligonucleotide synthesis can influence yield, purity, and scalability, while analytical approaches must provide the sensitivity and confidence needed to characterize increasingly complex molecules. Researchers are also seeking new ways to streamline assay development, accelerate gene assembly, and support emerging applications in protein engineering and functional genomics. Together, these challenges are driving innovation across the technologies used to create, analyze, and apply oligonucleotides.

In this SelectScience editorial feature, follow the oligonucleotide trail from synthesis to therapeutic delivery. Along the way, discover how scientists are overcoming some of the field's most pressing challenges, from improving oligonucleotide yield and scalability during manufacturing to generating confident analytical data and streamlining assay development. Explore the innovations helping researchers work more efficiently across the workflow, as well as the emerging approaches expanding opportunities in areas such as protein engineering, functional genomics, and therapeutic discovery. These expert insights offer a glimpse into the technologies shaping the next generation of oligonucleotide research.

Whether your focus is therapeutic development, genomics research, bioanalysis, or assay design, these stories highlight the innovation connecting every stage of the oligonucleotide journey. Read on to explore the technologies, applications, and expert insights shaping the future of oligonucleotide research and therapeutics.

HOW TO BUY eBook

Oligonucleotide Synthesis, Purification and Quantification Technology

Download eBook

Rethinking solid support chemistry for scalable siRNA manufacturing

Discover why early process development decisions matter as Dr. Catherine McKeen of LGC Diagnostics & Genomics explains how controlled pore glass technology can improve oligonucleotide yield, purity, and manufacturing efficiency.

Read article
Article

HILIC-inspired extraction solves oligonucleotide challenges

Follow Robert MacNeill, Scientific Director at Bristol Myers Squibb, as he navigates the challenges of oligonucleotide extraction and reveals how a HILIC-inspired approach enabled the development of a quantitative LC-MS method for human plasma analysis.

Read article
Article

PCR Forge cuts through the guesswork of multiplex PCR design

Designing multiplex PCR primers and probes does not have to be complex. Discover how a free online assay design tool can streamline development, with insights from Scott Monsma, Principal Bioinformatics Scientist at LGC Diagnostics & Genomics.

Read article
Article

Oligo pools to power innovation in protein engineering

Jeremy Lehmann from Agilent Technologies discusses how advances in oligo pool design are accelerating protein engineering and making next-generation therapeutic discovery more accessible.

Read article

Events & resources

Featured products

Never miss an update

Become a free SelectScience member and join our global scientific community to receive breaking news, expert interviews, and in‑depth insights straight to your inbox, along with regular newsletters.

Oligonucleotides: synthesis to delivery - SelectScience feature